VSM - Versum Materials, Inc.
| Previous Close | 52.98 |
| Open | 0.00 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 38500 |
| Day's Range | 52.98 - 53.00 |
| 52 Week Range | 25.02 - 53.00 |
| Volume | 2,297,003 |
| Avg. Volume | 922,446 |
| Market Cap | 5.789B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | 73.60 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
Here is What Hedge Funds Really Think About Materials, Inc. (VSM)?
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]
- American City Business Journals
Tempe's Versum Materials now part of global biotech, chemicals business
Merck KGaA intends to maintain Versum Material’s former Tempe headquarters as the hub for the combined electronic materials business in the U.S.
- GuruFocus.com
John Paulson's Top Gold Stocks
Paulson's gold investors group said $13 billion ready to be unlocked at gold producers Continue reading...
- Zacks
New Strong Sell Stocks for September 11th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.
- Zacks
Versum Materials (VSM) Misses Q3 Earnings and Revenue Estimates
Versum Materials (VSM) delivered earnings and revenue surprises of -11.48% and -7.95%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Earnings Preview: Versum Materials (VSM) Q3 Earnings Expected to Decline
Versum Materials (VSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Moody's
Merck KGaA -- Moody's: Versum shareholders approve acquisition by Merck KGaA
Merck KGaA ("Merck") announced that its transaction with Versum Materials, Inc ("Versum") had been approved at a special meeting among Versum's shareholders. Merck had signed a definitive agreement to acquire Versum for a consideration of $53 in cash in April this year, notes Moody's.
- Insider Monkey
Hedge Funds Have Never Been This Bullish On Versum Materials, Inc. (VSM)
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and recouped their losses by the end of the first quarter. […]
- Insider Monkey
Mason Capital’s Latest Moves
Mason Capital is a New York-based asset management firm that was launched by Kenneth Mario Garschina in 2000. It provides an additional office in London England. On March 28th, 2017, the fund managed around $3.5 billion in assets. Before launching his own hedge fund, Mr. Garschina worked at KS Capital Partners, first as a Research […]
- Zacks
Versum Materials (VSM) Q2 Earnings Meet, Sales Lag Estimates
Versum Materials (VSM) faced challenges from a softer demand environment in the second quarter.
- Reuters
Merck KGaA sees currencies supporting 2019 outlook
FRANKFURT (Reuters) - Germany's Merck KGaA, which is taking over U.S. electronic chemicals maker Versum Materials, said it expected a slight tailwind from foreign exchange effects supporting earnings growth ...
- Zacks
Earnings Preview: Versum Materials (VSM) Q2 Earnings Expected to Decline
Versum Materials (VSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Versum Materials (VSM) Matches Q2 Earnings Estimates
Versum Materials (VSM) delivered earnings and revenue surprises of 0.00% and -3.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Insider Monkey
Were Hedge Funds Right About Flocking Into Versum Materials, Inc. (VSM)?
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don't publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That's why we analyze the […]
- Moody's
EMD FINANCE LLC -- Moody's affirms Merck KGaA's ratings; stable outlook
NOTE: On April 17, 2019, the press release was corrected as follows: In the third sentence, the description of the affirmed rating was changed to short term issuer rating. Revised release follows. Paris, April 16, 2019 -- Moody's Investors Service, ("Moody's") has today affirmed Merck KGaA's ('Merck') issuer rating, senior unsecured Medium Term Note and subordinated ratings at Baa1, (P)Baa1 and Baa3 respectively.
- Benzinga
Merck KGaA Signs Versum Buyout Deal; Entegris Receives Termination Payment
The business combination received unanimous approval from the boards of the German pharmaceutical company and Versum, Merck said in a Friday press release. Versum is a supplier of process chemicals, gases and semiconductor manufacturing equipment.
- Reuters
Merck KGaA clinches $6.5 billion Versum takeover in bet on electrochemicals
Germany's Merck KGaA sealed a $6.5 billion (4.9 billion pounds) takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris. A bet on a recovery in electronic materials markets for semiconductor makers, the transaction will boost the share of profit that diversified Merck derives from high-tech chemicals to 27 percent from 19 percent previously. Merck, also maker of pharmaceuticals and biotech production gear, this week won the backing of Versum's board for its $53-per-share offer, lifted from $48 previously, having been spurned for weeks.
